• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Snapdragon Chemistry expands to new labs in Cambridge, MA

Snapdragon Chemistry expands to new labs in Cambridge, MA

April 5, 2016
CenterWatch Staff

Snapdragon Chemistry has moved to new lab facilities in Cambridge, Massachusetts. Snapdragon's corporate partner, Zaiput Flow Technologies, has also moved to the 85 Bolton Street site. This co-location will enhance the collaboration of these strategic partners and accelerate the development of advanced continuous chemical manufacturing technologies and solutions.

Snapdragon also has complete an investment round that enables both the significant expansion of its capabilities and technologies and the recruitment of additional top scientists in order to keep pace with the high demand for Snapdragon's services. Snapdragon is expanding its reaction profiling and analytical capabilities to include additional in-line process analytical technologies (PAT), including real-time and automated feedback control of process parameters. Snapdragon is also expanding its computational modeling capabilities, using reaction-profiling data in order to deliver "right-first-time" reactor design.

As part of the expansion, Snapdragon has hired Dr. Eric Fang as director of Chemistry and added both Ph.D. and BS level chemists. Snapdragon also plans to hire additional scientists and engineers in the near future.

Finally, in recognition of his contributions to the expansion of the company and the successful fundraising round, Snapdragon announced the election of Dr. Matthew Bio to president and CEO, succeeding the current president/CEO and co-founder Tim Jamison. Jamison will continue as chairman and as scientific and technical advisor to Snapdragon. Co-founder Aaron Beeler will also continue to serve on the board of directors and as scientific and technical advisor.

Zaiput Flow Technologies is an independently owned company dedicated to bringing innovative tools for continuous flow to the market. Zaiput specializes in the development of modular and scalable liquid-liquid separators and back pressure regulators for a variety of flow rates and with robust designs for harsh chemistries.

Snapdragon Chemistry is an independently owned CRO, headquartered created to deliver complete flow chemistry solutions to clients. Using advanced continuous manufacturing technology we are helping our clients to improve access to existing molecules and and discover new molecules. Snapdragon Chemistry offers continuous manufacturing development expertise enabling the development and commercialization of robust, practical and low cost chemical processes using advanced manufacturing technology.

Upcoming Events

  • 17May

    Three Data Trends to Consider Now When Developing Your Decentralized Clinical Trial Strategy

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing